Osteophysiology 2: Bone as an Endocrine Organ, Calcium Regulation, and Osteocalcin’s Cognitive Role

Bone as an Organ in the Body

• Bone is more than a structural tissue: it participates in calcium regulation and acts as an endocrine organ.
• Key hormone discussed: osteocalcin (OCN), a bone-derived factor with effects on distant organs, especially the brain.
• The material emphasizes a bone–brain communication axis: bone releases osteocalcin, which can influence brain function and behavior.

Calcium Regulation: Bone's Role

• Bone functions as a dynamic reservoir for calcium, enabling rapid exchange with the bloodstream to help maintain extracellular Ca2+ levels.
• In the context of calcium homeostasis, bone participates in regulating systemic calcium by adjusting deposition (formation) and resorption (breakdown).
• The transcript notes the topic as an objective: to describe how bone participates in calcium regulation and to describe bone as an endocrine organ. While detailed hormonal pathways are not fully spelled out in the garbled slides, the concept is that bone both stores calcium and communicates with other systems to help regulate calcium balance.
• Conceptual metaphor: bone acts like a calcium bank, borrowing or depositing calcium as needed to stabilize blood calcium levels.

Osteocalcin: A Cognitive Hormone

• Osteocalcin (OCN) is a hormone produced by bone-forming cells (osteoblasts) and secreted into the bloodstream.
• OCN exists in circulating plasma and can exist in different carboxylation states; the undercarboxylated form is the hormonally active form in some models.
• OCN provides a direct signaling link from bone to the brain, influencing cognitive and emotional behaviors.
• Key experimental observations (as described in the slides):
  • Plasma source effects:
  • Young WT (wild-type) plasma contains functional osteocalcin that can improve brain-related outcomes.
  • Plasma from young Ocn-/- mice lacks osteocalcin and fails to produce the same brain effects, underscoring that OCN is necessary for these effects.
  • Aged WT plasma can be compared to young WT plasma to assess age-related differences in osteocalcin’s brain effects (the slides show a contrast among Young WT, Young Ocn-/-, and Aged WT contexts).
  • OCN administration and receptor involvement:
  • Administration of OCN (or presence of OCN in plasma) is linked to improvements in memory and reductions in anxiety-like behavior in the models described.
  • The receptor involved in the brain is GPR158 (Gpr158), a neuronal receptor for osteocalcin.
  • The signaling pathway involves IP3 (inositol trisphosphate), indicating a G-protein–coupled signaling mechanism: $IP_3$.
  • Blood–brain barrier: OCN must cross the blood–brain barrier to affect brain regions such as the hippocampus (CA3 region).
  • Brain regions and downstream targets:
  • Primary brain region mentioned: CA3 of the hippocampus.
  • Other brain areas implicated in the pathway include the Ventral Tegmental Area (VTA), Dorsal Raphe Nucleus (DRN), Medial Raphe Nucleus (MRN).
  • Molecular and neurochemical consequences:
  • OCN signaling is associated with increased brain-derived neurotrophic factor (BDNF).
  • There is modulation of monoamine neurotransmitters: serotonin, dopamine, norepinephrine, and the inhibitory neurotransmitter GABA.
  • Behavioral outcomes:
  • Spatial learning and memory improve with functional osteocalcin signaling.
  • Anxiety-like behavior decreases with osteocalcin activity.
• Mechanistic summary (as depicted):
  • Osteocalcin binds to its receptor on neurons, notably GPR158 (Gpr158).
  • This receptor engagement activates the IP3 signaling pathway (Gq family signaling).
  • Downstream effects include upregulation of BDNF and modulation of monoamine systems, contributing to improved memory and reduced anxiety.
• Immunological/experimental controls shown:
  • OCN IgG controls vs anti-OCN IgG demonstrate specificity: neutralizing osteocalcin with an anti-OCN antibody reduces the observed behavioral effects, supporting a causal role for OCN in these brain/behavior changes.
• Conceptual summary: bone-derived osteocalcin acts as a cognitive hormone that travels to the brain, engages a receptor (GPR158), activates IP3 signaling, boosts BDNF, modulates neurotransmitters, and ultimately improves memory while reducing anxiety-like behavior.

Mechanisms and Signaling Details

• Receptor: $GPR158$ (Gpr158) on brain neurons mediates osteocalcin’s effects.
• Signaling cascade: $IP_3$ pathway is involved following receptor activation.
• Neurochemical changes:
  • Increased brain-derived neurotrophic factor (BDNF).
  • Altered levels of serotonin, dopamine, norepinephrine, and GABA in relevant circuits.
• Target brain regions: CA3 region of the hippocampus; networks involving reward/mood centers such as VTA, DRN, and MRN.
• Functional outcomes tied to signaling:
  • Enhanced spatial learning and memory.
  • Reduced anxiety-like behavior.

Brain Regions and Behavioral Outcomes

• CA3 hippocampus: a critical site for osteocalcin’s effects on memory-related processes.
• Spatial learning and memory: improved in conditions with active osteocalcin signaling.
• Anxiety-like behavior: decreased with osteocalcin activity.
• Monoaminergic systems implicated: serotonin, dopamine, norepinephrine; influence on GABAergic transmission contributing to mood regulation.

Experimental Evidence and Illustrative Scenarios

• Plasma transfer experiments:
  • Young WT plasma containing osteocalcin improves cognitive outcomes in recipients.
  • Young Ocn-/- plasma (lacking osteocalcin) does not yield the same cognitive benefits, highlighting the necessity of OCN.
  • The inclusion of recombinant or exogenous OCN in aged systems can modulate memory and anxiety markers via GPR158 signaling.
• Receptor-specific manipulation:
  • GPR158 involvement is supported by signaling and functional outcomes linked to OCN activity.
• Antibody neutralization experiments:
  • Anti-OCN IgG reduces or blocks the memory-enhancing and anxiolytic effects of osteocalcin, whereas control IgG does not, underscoring specificity.
• Blood–brain barrier role:
  • OCN must cross the bloodstream–brain barrier to exert its central effects, localizing to hippocampal regions such as CA3.

Implications, Connections, and Relevance

• Conceptual significance:
  • Demonstrates a clear example of a skeletal endocrine signal influencing brain function and behavior, extending the view of bone beyond structure to systemic regulation.
  • Supports the broader principle of neuroendocrine crosstalk and multi-organ regulation of cognition and mood.
• Real-world relevance:
  • Aging and cognitive health: osteocalcin signaling may link bone health with memory and anxiety, suggesting potential therapeutic angles for aging-related cognitive decline or mood disorders.
  • Osteoporosis therapies and bone-targeted interventions could have downstream effects on brain function, mood, and memory through osteocalcin pathways.
• Foundational connections:
  • Aligns with endocrine principles: organ systems communicate via hormones to influence distant targets, including the CNS.
  • Integrates bone physiology with neuroscience by showing a bone-derived hormone that modulates neural plasticity and behavior.
• Ethical and practical considerations:
  • Translating mouse model findings to humans requires careful consideration of safety, dosing, and long-term effects of manipulating osteocalcin signaling.
  • Potential for biomarker development: circulating osteocalcin levels as indicators of bone–brain hormonal signaling status.

Notes on Content Quality and Garbled Sections

• Several pages in the transcript (pages 3–9 and parts of page 10) are garbled or contain unreadable text, making some details unclear or missing.
• The cohesive narrative that can be extracted centers on the osteocalcin–GPR158 axis and its cognitive/behavioral consequences, with the emphasis on CA3, BDNF, and monoamines as downstream effects.
• Page 14 provides a consolidated schematic (from Nat Rev Endocrinol. 2018) that supports the above mechanisms and links to behavioral outcomes, including the blood–brain barrier and receptor signaling.

Key Terms and Concepts (Glossary)

• Osteocalcin (OCN): a bone-derived hormone; active in its undercarboxylated form; crosses the blood–brain barrier to act on the brain.
• GPR158 (Gpr158): a brain receptor for osteocalcin mediating its neural effects.
• IP3: inositol trisphosphate, a second messenger in G protein–coupled signaling cascades.
• BDNF: brain-derived neurotrophic factor, a critical mediator of synaptic plasticity and learning.
• CA3: a subregion of the hippocampus important for memory processes.
• VTA: ventral tegmental area, involved in reward and motivation circuits.
• DRN: dorsal raphe nucleus, a major source of serotonin.
• MRN: medial raphe nucleus, also involved in serotonergic signaling.
• IgG control / anti-OCN IgG: antibody controls used to test the specificity of osteocalcin’s effects.
• Ocn-/-: osteocalcin knockout mouse model used to assess osteocalcin-dependent phenotypes.
• Spatial learning and memory: cognitive domains assessed to determine hippocampal-dependent functions.
• Anxiety-like behavior: rodent behavioral metric used to infer anxiety states.

References

• Nat Rev Endocrinol. 2018 Mar;14(3):174-182. (Osteocalcin as a cognitive hormone and the bone–brain endocrine axis)